The Journal of Urology · 1995 · 122 citations · 12 references
MedicineOncologyUrologyEndocrine OncologyGenitourinary OncologyUrologic OncologyEndocrine SequelaeHormonal Cancer TherapyProstate CancerProstate-specific Antigen TestingAdvanced Prostate Cancer TherapyAndrogen WithdrawalMegestrol Acetate TherapyMetastatic Hormone-sensitive Prostate Cancer TherapyProstate Cancer Hormonal TherapyProstate Cancer Hormone TherapyProstate-specific Antigen Kinetics
We report a dramatic decrease in prostate specific antigen in response to the discontinuation of megestrol acetate in a patient with progressive metastatic prostate cancer. Our case demonstrates that withdrawal responses may occur with steroidal and nonsteroidal antiandrogens.
12